Purolite Awarded Queen’s Award for Enterprise
Purolite has received the Queen’s Award for Enterprise in the International Trade category.
Purolite, an Ecolab company and manufacturer of synthetic and agarose-based resins, has been awarded the Queen’s Award for Enterprise in the International Trade category.
Purolite is among the 232 organizations to be recognized nationally with a Queen’s Award for Enterprise. The company was selected for its success in innovation and international trade, as well as resilience throughout the COVID-19 pandemic.
The Queen’s Award for Enterprise, established in 1965, is the United Kingdom’s highest accolade for business success. The awards, granted annually, acknowledge firms that have excelled in exporting, social or environmental good work, or innovation.
Leighton Davies, finance director at Purolite, has received an invitation to the Buckingham Palace awards reception that is to be hosted by Prince Charles.
“It’s a tremendous honor to have won the Queen’s Award for Enterprise. I’m immensely proud of this achievement and would like to thank the fantastic teams we have in place all over the world, as well as the continued support of our valued customers,” commented Hayley Crowe, SVP and general manager of Purolite, upon the company receiving the award.
Source: Purolite
Regeneron Treatment for Multiple Myeloma Gets Conditional Marketing Approval from EC
April 29th 2025The indication is specific to patients who have received at least three prior therapies, including a proteasome inhibitor, immunomodulatory agent, and anti-CD38 monoclonal antibody, and have demonstrated disease progression on the last therapy.
MHRA Approves GSK Therapy Combinations for Multiple Myeloma
April 21st 2025Belantamab mafodotin is approved in combination with bortezomib plus dexamethasone in patients who have had at least one prior therapy, and in combination with pomalidomide plus dexamethasone for those who have had a prior therapy including lenalidomide.
